This collection
is approved as amended by FDA's revisions of 9/2/04 on the
following conditions: If FDA determines that modifications to the
collection are necessary during the course of the pilot (e.g.,
expansion of the number of respondents, questions asked), FDA shall
request OMB approval of the changes through a memorandum explaining
the need for such changes prior to initiating a revised collection.
Once approved, OMB will amend the file accordingly. FDA should also
send OMB an update on the progress of the pilot prior to the
development of the regulation.
Inventory as of this Action
Requested
Previously Approved
09/30/2007
09/30/2007
09/30/2004
3,960
0
2,045
2,680
0
1,334
0
0
0
This pilot includes: continuing to
implement an electronic version of the portions of the 3500A form
used by user facilities to report adverse events occurring with
medical devices (which includes past approved additional voluntary
questions); and continuing to implement a sharing of device
problems between the reporting sites with the opportunity to
provide solutions. Participation in this pilot is voluntary. During
the first three years of the program 180 facilities were enrolled.
It is anticipated that the number of voluntary participants will
increase to approximately..
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.